BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 1406237)

  • 1. [Toxicological basis for evaluating health risk].
    Rolecki R; Dutkiewicz T; Kończalik J
    Med Pr; 1992; 43(3):173-81. PubMed ID: 1406237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evolution of industrial toxicology toward vanishing doses and the human genome].
    Colombi A; Buratti M; Rubino FM; Giampiccolo R; Pulvirenti S; Brambilla G
    Med Lav; 2003; 94(1):69-82. PubMed ID: 12768958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paradigm lost, paradigm found: the re-emergence of hormesis as a fundamental dose response model in the toxicological sciences.
    Calabrese EJ
    Environ Pollut; 2005 Dec; 138(3):379-411. PubMed ID: 16098930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fundamental carcinogenic processes and their implications for low dose risk assessment.
    Crump KS; Hoel DG; Langley CH; Peto R
    Cancer Res; 1976 Sep; 36(9 pt.1):2973-9. PubMed ID: 975067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future of toxicology--low-dose toxicology and risk--benefit analysis.
    Rietjens IM; Alink GM
    Chem Res Toxicol; 2006 Aug; 19(8):977-81. PubMed ID: 16918235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the national toxicology program report on carcinogens.
    Rodu B; Cole P; Mandel JS
    Regul Toxicol Pharmacol; 2012 Oct; 64(1):186-8. PubMed ID: 22810056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Environmental mutagenesis and use of biomarkers in cancer risk prediction].
    Cuenca P; Ramírez V
    Rev Biol Trop; 2004 Sep; 52(3):585-90. PubMed ID: 17361552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomonitoring equivalents: a screening approach for interpreting biomonitoring results from a public health risk perspective.
    Hays SM; Becker RA; Leung HW; Aylward LL; Pyatt DW
    Regul Toxicol Pharmacol; 2007 Feb; 47(1):96-109. PubMed ID: 17030369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Calculation of the median effective dose and median effective time using a generalized model based on the Waibull distribution].
    Antomonov MIu; Bogorad VS
    Gig Sanit; 1992; (5-6):61-4. PubMed ID: 1398186
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mathematical dose-effect models in the study of carcinogenesis].
    Parfenov IuD
    Vopr Onkol; 1986; 32(1):9-22. PubMed ID: 3511610
    [No Abstract]   [Full Text] [Related]  

  • 12. [Problems in prediction of toxicity and risk of effects of chemical substances on public health].
    Rumiantsev GI; Novikov SM
    Gig Sanit; 1997; (6):13-8. PubMed ID: 9483844
    [No Abstract]   [Full Text] [Related]  

  • 13. A goal-oriented approach to reducing industrially related carcinogenic risks.
    Deisler PF
    Drug Metab Rev; 1982; 13(5):875-911. PubMed ID: 6754313
    [No Abstract]   [Full Text] [Related]  

  • 14. [Exposure to carcinogens in work environment today. State of the art, problems and prospects raised by the Law 626/94].
    Carnevale F; Baldasseroni A
    Med Lav; 1998; 89(2):102-9. PubMed ID: 9673099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [International-cooperative studies on carcinogenicity evaluation of environmental chemicals].
    Hayashi Y
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 2):579-84. PubMed ID: 3985632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Various suggestions on the unification of methods for experimental substantiation of maximum permissible concentration of chemical carcinogens].
    Litvinov NN; Titova TA
    Gig Sanit; 1977 Oct; (10):69-73. PubMed ID: 598727
    [No Abstract]   [Full Text] [Related]  

  • 17. Precautionary principle for toxic chemicals - no alternative to safeguard societal benefits.
    Jostmann T
    Hum Exp Toxicol; 2007 Nov; 26(11):847-9; discussion 875-6. PubMed ID: 18042578
    [No Abstract]   [Full Text] [Related]  

  • 18. Biologically based models for risk assessment.
    Portier CJ; Hoel DG; Kaplan NL; Kopp A
    IARC Sci Publ; 1990; (104):20-8. PubMed ID: 2228117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of carcinogenicity risks in work environment].
    Terracini B
    Med Lav; 1998; 89(2):98-101. PubMed ID: 9673098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Toxicological evaluation of inhalation noxae: test methods, assessment of toxic action and hazard potential, threshold limit values].
    Kleinsasser N
    Laryngorhinootologie; 2004 May; 83 Suppl 1():S36-53. PubMed ID: 15118947
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.